Buy - Price 35.59 on June 15 by McAdams Wright Ragen We have added H.J. Heinz to the Focus List -- Value with a $44 price target, based on 14x our fiscal year 20012 (April) estimate of $3.15 per share. Based on today's price, and including the dividend, which currently yields 4.72%, we're targeting a two-year total return of more than 30%. We regard HNZ as an attractively-priced consumer staple, trading at about 13.2x forward earnings, with a high-quality brand portfolio, a loyal customer base, and, in our opinion, an ultra-safe dividend with an above-average yield. Earnings have been buffeted by unfavorable currency-exchange rates, commodity inflation, and the global economic environment. Although management is targeting FY10 (April) earnings growth of 5% to 8% in constant currencies (from $2.90 per share in FY09), the currency impact is likely to shave $0.46 per share from earnings, resulting in reported earnings guidance of $2.60 to $2.70 per share. Market cap: $11.2 billion.

Hold - Price 3.99 on June 15 by Wedbush Morgan While it is clear that management is working diligently to revive Crocs ' business, management is still in the process of getting a handle on a still-deteriorating business. In particular, we believe that the company is still seeking a workable retail model, especially at its U.S. concept stores, and is working to reduce inventory and stabilize sales. Product, distribution and customer-service changes are a key first step to reviving business. We believe that management recognizes that it needs to better manage its relationships with its retail partners, including controlling distribution, offering more unique product to each channel, and managing the delivery process better. We are reducing our 2009 EPS estimate to $(0.89) from $(0.78), 2010 EPS estimate to $(0.12) from $0.06 and maintaining suspended price target. Our lower numbers reflect that various parts of Crocs' business are worse than we previously believed, and that the current environment makes it difficult to quickly turn around a flagging brand. Near term, we do not see significant upside potential for shares of CROX; however, we believe that over the next three to five years, the company can remake its business and offer both meaningful profitability and stock gains. Market cap: $331 million.

Buy - Price 21.70 on June 16 by Merriman Curhan Ford We are initiating coverage of FEIC with a Buy rating. FEI is a market leader in advanced electron microscopy instruments serving the electronics, industrial and life-sciences market; it is well positioned for double-digit percentage secular growth in the nanotech/clean technology market. We believe FEI's tool orders have likely bottomed in 1Q09 as orders begin to improve from share-gain opportunities in the life-science and industrial markets. Furthermore, 2H09 orders could exceed 1H09 orders by 10% due to Stimulus funding benefiting national/university labs focusing on clean technology and long-term R&D programs. Our FY10 EPS estimate of $1.30 (the Street is at $1.29) could prove conservative given our conservative margin assumptions. With an annualized 2H10 EPS run rate of $1.54 and a historical growth P/E for capital equipment in the 18x to 22x range, we believe the stock should be valued in the range of $28 to $32. Market cap: $840 million.

Buy - Price 35.84 on June 17 by Jefferies & Co. First-quarter EPS came in at $0.42, well ahead of our $0.35 estimate and consensus of $0.34. On the beat, we are raising our FY10 and FY11 EPS to $2.95 and $3.28 from $2.90 and $3.10, respectively. Smaller-screen LCDs [liquid crystal displays] are growing as fast as large screens, with LED [light-emitting diode] TVs experiencing strong growth. Best Buy currently has 9 LED SKUIs, and will be expanding the assortment as the year progresses. Market share accelerated as it gained 200 basis points over the three-month period ending in April. The March share gain was 240 basis points. April came in slightly below this, and May has been consistent with these figures. Our 12-month price target of $43 is based on BBY shares selling at 14.5x our FY10 EPS estimate of $2.95. This is in line with its historical forward 3- and 5-year P/E. We would normally argue for even higher P/E during the early cycle retail trade, but we believe the market will discount potential risk from product-cycle maturation. Market cap: $14.8 billion.